Executive Medical Director - Cardio-Renal at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Physician/scientist with broad scientific expertise in cardiovascular diseases (additional experience in renal diseases is a bonus)
Demonstrated track record of developing clinical development strategies and trials in diseases including, but not limited to, heart failure, ASCVD, hypertension, pulmonary hypertension, and/or CKD
Scientific training, clinical expertise, and relevant experience to develop preclinical strategies for first-in-human trials and clinical development strategies across all phases
Awareness and compliance with current local and international regulations, laws, guidance (e.g., FDA, ICH, CPMP), Good Clinical Practices (GCPs), company standards, Lilly policies, procedures, integrity agreements, and Principles of Medical Research

Responsibilities

Report to the Senior Vice President of Cardio-Renal Research and Early Clinical Development
Work with preclinical teams to develop sound preclinical strategies to progress molecules to first-in-human trials
Develop sound clinical development strategies and trials across all phases of development consistent with best clinical practices
Conduct and support clinical trials in each phase of development
Support commercial decisions for compounds in various disease states and therapeutic indications as determined by Cardio-Renal and DOCTA management
Supervise the implementation of global clinical trials
Handle the reporting of adverse events as mandated by corporate patient safety
Review protocols, study reports, publications, regulatory submissions, and data dissemination
Take a leadership role in interactions with regulatory bodies worldwide and other governmental agencies to advance clinical development
Engage external medical and scientific experts to represent Lilly, develop molecules, and implement clinical trials
Collaborate with Preclinical groups, Clinical Pharmacology, Health Outcomes, and New Product Planning to develop and maintain Draft Launch Labels and Value Propositions addressing key customer needs, consistent with molecule characteristics and clinical strategies
Contribute to global alignment of clinical strategy and plans with business unit and LRL priorities
Understand and stay updated with preclinical information and its implications

Skills

Clinical Development

Cardiovascular Diseases

Renal Diseases

Heart Failure

ASCVD

Hypertension

Pulmonary Hypertension

CKD

Preclinical Strategies

Clinical Trials

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free